(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1605108 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GINS1 mRNA CTD PMID:22079256 1,1-dichloroethene increases expression ISO RGD:1558168 6480464 vinylidene chloride results in increased expression of GINS1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression ISO RGD:1558168 6480464 1, 2-Dimethylhydrazine results in increased expression of GINS1 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of GINS1 mRNA CTD PMID:30723492 17beta-estradiol increases expression ISO RGD:1605108 6480464 Estradiol results in increased expression of GINS1 mRNA CTD PMID:16474171 , PMID:19167446 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1558168 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1558168 6480464 [2 more ... CTD PMID:25510870 5-fluorouracil increases response to substance ISO RGD:1558168 6480464 GINS1 gene mutant form results in increased susceptibility to Fluorouracil CTD PMID:18984863 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of GINS1 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of GINS1 mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO RGD:1605108 6480464 Aflatoxin B1 affects the expression of GINS1 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of GINS1 mRNA CTD PMID:25378103 all-trans-retinoic acid decreases expression ISO RGD:1605108 6480464 Tretinoin results in decreased expression of GINS1 mRNA CTD PMID:16054129 amiodarone increases expression ISO RGD:1605108 6480464 Amiodarone results in increased expression of GINS1 mRNA CTD PMID:19774075 azathioprine decreases expression ISO RGD:1605108 6480464 Azathioprine results in decreased expression of GINS1 mRNA CTD PMID:22623647 benzo[a]pyrene increases expression ISO RGD:1605108 6480464 Benzo(a)pyrene results in increased expression of GINS1 mRNA CTD PMID:32234424 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1605108 6480464 7 more ... CTD PMID:19150397 , PMID:20382639 bisphenol A increases expression ISO RGD:1605108 6480464 bisphenol A results in increased expression of GINS1 mRNA CTD PMID:16474171 bisphenol A affects expression ISO RGD:1605108 6480464 bisphenol A affects the expression of GINS1 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:1605108 6480464 bisphenol A results in decreased expression of GINS1 mRNA CTD PMID:29275510 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of GINS1 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GINS1 mRNA CTD PMID:25181051 butanal decreases expression ISO RGD:1605108 6480464 butyraldehyde results in decreased expression of GINS1 mRNA CTD PMID:26079696 cadmium atom decreases expression ISO RGD:1605108 6480464 Cadmium results in decreased expression of GINS1 mRNA CTD PMID:21120746 cadmium dichloride increases expression ISO RGD:1605108 6480464 Cadmium Chloride results in increased expression of GINS1 mRNA CTD PMID:26472689 calcitriol multiple interactions ISO RGD:1605108 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of GINS1 mRNA CTD PMID:21592394 calcitriol decreases expression ISO RGD:1605108 6480464 Calcitriol results in decreased expression of GINS1 mRNA CTD PMID:21592394 carbon nanotube increases expression ISO RGD:1558168 6480464 Nanotubes, Carbon analog results in increased expression of GINS1 mRNA, Nanotubes, Carbon results in increased expression of GINS1 mRNA CTD PMID:25554681 cisplatin multiple interactions ISO RGD:1605108 6480464 Cisplatin promotes the reaction [Piroxicam results in decreased expression of GINS1 mRNA] CTD PMID:21858171 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of GINS1 mRNA CTD PMID:22023808 cobalt dichloride decreases expression ISO RGD:1605108 6480464 cobaltous chloride results in decreased expression of GINS1 mRNA CTD PMID:19320972 copper atom multiple interactions ISO RGD:1605108 6480464 [NSC 689534 binds to Copper] which results in decreased expression of GINS1 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1605108 6480464 [NSC 689534 binds to Copper] which results in decreased expression of GINS1 mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO RGD:1605108 6480464 Copper Sulfate results in decreased expression of GINS1 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:1605108 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol increases expression ISO RGD:1605108 6480464 Coumestrol results in increased expression of GINS1 mRNA CTD PMID:19167446 cyclosporin A decreases expression ISO RGD:1605108 6480464 Cyclosporine results in decreased expression of GINS1 mRNA CTD PMID:20106945 more ... dibutyl phthalate decreases expression ISO RGD:1558168 6480464 Dibutyl Phthalate results in decreased expression of GINS1 mRNA CTD PMID:17361019 , PMID:21266533 dioxygen decreases expression ISO RGD:1605108 6480464 Oxygen deficiency results in decreased expression of GINS1 mRNA CTD PMID:26516004 dioxygen multiple interactions ISO RGD:1558168 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GINS1 mRNA CTD PMID:30529165 Enterolactone multiple interactions ISO RGD:1605108 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS1 mRNA CTD PMID:19167446 flutamide increases expression EXP 6480464 Flutamide results in increased expression of GINS1 mRNA CTD PMID:24793618 furan increases expression EXP 6480464 furan results in increased expression of GINS1 mRNA CTD PMID:25539665 genistein increases expression ISO RGD:1605108 6480464 Genistein results in increased expression of GINS1 mRNA CTD PMID:16474171 isotretinoin decreases expression ISO RGD:1605108 6480464 Isotretinoin results in decreased expression of GINS1 mRNA CTD PMID:20436886 leflunomide decreases expression ISO RGD:1605108 6480464 leflunomide results in decreased expression of GINS1 mRNA CTD PMID:28988120 methylparaben decreases expression ISO RGD:1605108 6480464 methylparaben results in decreased expression of GINS1 mRNA CTD PMID:31745603 N-Nitrosopyrrolidine decreases expression ISO RGD:1605108 6480464 N-Nitrosopyrrolidine results in decreased expression of GINS1 mRNA CTD PMID:32234424 nickel sulfate decreases expression ISO RGD:1605108 6480464 nickel sulfate results in decreased expression of GINS1 mRNA CTD PMID:22714537 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of GINS1 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of GINS1 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1558168 6480464 [NOTCH3 gene mutant form affects the susceptibility to Ozone] which results in increased expression of GINS1 mRNA CTD PMID:25658374 paracetamol affects expression ISO RGD:1558168 6480464 Acetaminophen affects the expression of GINS1 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1605108 6480464 Acetaminophen results in decreased expression of GINS1 mRNA CTD PMID:29067470 paracetamol increases expression ISO RGD:1605108 6480464 Acetaminophen results in increased expression of GINS1 mRNA CTD PMID:22230336 perfluorononanoic acid decreases expression ISO RGD:1605108 6480464 perfluorononanoic acid results in decreased expression of GINS1 mRNA CTD PMID:32588087 phenobarbital affects expression ISO RGD:1558168 6480464 Phenobarbital affects the expression of GINS1 mRNA CTD PMID:23091169 pirinixic acid increases expression ISO RGD:1558168 6480464 pirinixic acid results in increased expression of GINS1 mRNA CTD PMID:23811191 piroxicam multiple interactions ISO RGD:1605108 6480464 Cisplatin promotes the reaction [Piroxicam results in decreased expression of GINS1 mRNA] CTD PMID:21858171 piroxicam decreases expression ISO RGD:1605108 6480464 Piroxicam results in decreased expression of GINS1 mRNA CTD PMID:21858171 potassium chromate decreases expression ISO RGD:1605108 6480464 potassium chromate(VI) results in decreased expression of GINS1 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1605108 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GINS1 mRNA CTD PMID:22079256 propanal decreases expression ISO RGD:1605108 6480464 propionaldehyde results in decreased expression of GINS1 mRNA CTD PMID:26079696 resveratrol increases expression ISO RGD:1605108 6480464 resveratrol results in increased expression of GINS1 mRNA CTD PMID:19167446 resveratrol multiple interactions ISO RGD:1605108 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of GINS1 mRNA CTD PMID:19167446 silicon dioxide decreases expression ISO RGD:1605108 6480464 Silicon Dioxide analog results in decreased expression of GINS1 mRNA CTD PMID:23806026 sodium arsenite decreases expression ISO RGD:1605108 6480464 sodium arsenite results in decreased expression of GINS1 mRNA CTD PMID:22714537 sodium arsenite affects methylation ISO RGD:1605108 6480464 sodium arsenite affects the methylation of GINS1 gene CTD PMID:28589171 sodium arsenite increases expression ISO RGD:1605108 6480464 sodium arsenite results in increased expression of GINS1 mRNA CTD PMID:28595984 , PMID:29301061 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of GINS1 mRNA CTD PMID:25993096 sunitinib decreases expression ISO RGD:1605108 6480464 Sunitinib results in decreased expression of GINS1 mRNA CTD PMID:31533062 testosterone decreases expression ISO RGD:1605108 6480464 Testosterone results in decreased expression of GINS1 mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:1605108 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of GINS1 mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:1558168 6480464 Carbon Tetrachloride results in increased expression of GINS1 mRNA CTD PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of GINS1 mRNA CTD PMID:23411599 titanium dioxide increases expression ISO RGD:1558168 6480464 titanium dioxide results in increased expression of GINS1 mRNA CTD PMID:23557971 , PMID:27760801 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of GINS1 mRNA CTD PMID:30012374 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of GINS1 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of GINS1 mRNA CTD PMID:25729387 trimellitic anhydride increases expression ISO RGD:1558168 6480464 trimellitic anhydride results in increased expression of GINS1 mRNA CTD PMID:19042947 tungsten increases expression ISO RGD:1558168 6480464 Tungsten results in increased expression of GINS1 mRNA CTD PMID:30912803 urethane decreases expression ISO RGD:1605108 6480464 Urethane results in decreased expression of GINS1 mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:1605108 6480464 Valproic Acid results in increased expression of GINS1 mRNA CTD PMID:29154799
Gene-Chemical Interaction Annotations
